IperionX Limited ($IPX) reported quarterly revenue of $38.9 million, down 15.3% from a year earlier, while gross profit fell 30.6% to $4.9 million. Operating profit also came in at $4.9 million, reflecting the same year-over-year decline.
Net income attributable to common shareholders was $3.6 million, down 35.2% from the prior year, and diluted earnings per share declined 25% to $0.03. Cost of sales totaled $34.0 million, a 12.5% decrease year over year.
Cash flow from operating activities was negative $11.9 million, while spending on property, plant and equipment was $1.0 million. The company ended the period with $62.3 million in cash and cash equivalents and $33.0 million in total liabilities.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
IperionX Limited Insider Trading Activity
IperionX Limited insiders have traded $IPX stock on the open market 11 times in the past 6 months. Of those trades, 11 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IPX stock by insiders over the last 6 months:
- TODD HANNIGAN (Executive Chairman) has made 5 purchases buying 1,230,225 shares for an estimated $4,679,871 and 0 sales.
- ANASTASIOS ARIMA (Chief Executive Officer) has made 4 purchases buying 728,520 shares for an estimated $2,783,963 and 0 sales.
- TOBY EDGCUMBE SYMONDS (President) purchased 11,000 shares for an estimated $262,552
- R TONY TRIPENY purchased 4,187 shares for an estimated $99,463
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
IperionX Limited Hedge Fund Activity
We have seen 28 institutional investors add shares of IperionX Limited stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VAN ECK ASSOCIATES CORP added 842,746 shares (+63.0%) to their portfolio in Q1 2026, for an estimated $21,945,105
- WOODLINE PARTNERS LP added 300,062 shares (+177.5%) to their portfolio in Q1 2026, for an estimated $7,813,614
- SHAY CAPITAL LLC added 77,755 shares (+57.5%) to their portfolio in Q1 2026, for an estimated $2,024,740
- MORGAN STANLEY removed 64,980 shares (-49.8%) from their portfolio in Q1 2026, for an estimated $1,692,079
- PRIVATE ADVISOR GROUP, LLC removed 63,111 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,876,290
- JANE STREET GROUP, LLC removed 57,771 shares (-44.8%) from their portfolio in Q1 2026, for an estimated $1,504,356
- MILLENNIUM MANAGEMENT LLC added 47,289 shares (+40.3%) to their portfolio in Q1 2026, for an estimated $1,231,405
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
IperionX Limited Analyst Ratings
Wall Street analysts have issued reports on $IPX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 03/27/2026
To track analyst ratings and price targets for IperionX Limited, check out Quiver Quantitative's $IPX forecast page.
IperionX Limited Price Targets
Multiple analysts have issued price targets for $IPX recently. We have seen 2 analysts offer price targets for $IPX in the last 6 months, with a median target of $53.5.
Here are some recent targets:
- Gregory Lewis from BTIG set a target price of $55.0 on 06/05/2026
- Lucas Pipes from B. Riley Securities set a target price of $52.0 on 03/13/2026
